Revolution Medicines, Inc.
Public
RMD
SectorHealthcare
CountryUnited States
Market cap31.13B
Revolution Medicines, Inc.,"A clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers."
